Historical record - last NADAC effective date: 1/6/2023
Product Information
STEGLATRO 5 MG TABLET is a brand product labeled by Merck Sharp & Dohme LLC, priced at $10.9002 per EA under NDC 00006536307. Its NADAC has been published 262 times since Aug 22, 2018.
FDA first approved this application on Dec 19, 2017.
Strength
5 mg/1
Manufacturer
Merck Sharp & Dohme LLCNDC
00006536307
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
1/6/2023
Active Ingredients
ERTUGLIFLOZIN PIDOLATEApproval Type
New Drug (NDA)
FDA Application
NDA209803FDA Approved
12/19/2017
On Market Since
12/19/2017
Price Statistics
The NADAC for STEGLATRO 5 MG TABLET has been published 262 times since Aug 22, 2018, and over the history we have for it it has risen 25.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.9002 per EA |
|---|---|
| All-time high | $10.9002 (Aug 23, 2023) |
| All-time low | $8.5924 (Oct 17, 2018) |
| Median price | $9.9023 |
| Average price | $9.7584 |
| Largest weekly change | +5.0% (Jan 18, 2023) |
| Weeks tracked | 262 |
| Tracking since | Aug 22, 2018 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
0.0%
5Y
+10.0%
All
+25.6%
Last surveyed Aug 23, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of STEGLATRO 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for STEGLATRO 5 MG TABLET, manufactured by Merck Sharp & Dohme LLC, is $10.9002 per EA (NDC 00006536307), effective Aug 23, 2023.
How has the price of STEGLATRO 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for STEGLATRO 5 MG TABLET has risen 25.6%. It has been tracked across 262 weekly CMS publications since Aug 22, 2018.
What are the highest and lowest recorded NADAC prices for STEGLATRO 5 MG TABLET?
Since Aug 22, 2018, the NADAC for STEGLATRO 5 MG TABLET has ranged from a low of $8.5924 (Oct 17, 2018) to a high of $10.9002 (Aug 23, 2023), with a median of $9.9023 per EA.
Are there cheaper alternatives to STEGLATRO 5 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as STEGLATRO 5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures STEGLATRO 5 MG TABLET?
STEGLATRO 5 MG TABLET (NDC 00006536307) is labeled by Merck Sharp & Dohme LLC, and CMS classifies it as a brand product.